Myomo, Inc.

AMEX:MYO

Medical - Devices

Healthcare
$1.25 -8.80%

-$0.13 today

Market cap
$50.12M
Beta
1.46
P/E (TTM)
-3.6
EPS (TTM)
-$0.36
52W Low $0.61High $2.68

Volume 0.21M

Average 0.62M

MYO Sales of Investments

Cash received from selling or redeeming investments.

Myomo, Inc.AMEX: MYO

Sales of Investments · Q1 FY2026 · quarter ended Mar 2026

Sales of investments outflow grows to $0

Q1 FY2026 sales of investments was $0, compared with $0 a year earlier. Trailing-twelve-month sales of investments was $1.74M. Over 3 fiscal years it compounded at +63.6% a year.

Context

  • Sales of investments amounted to 4.3% of revenue in FY2025, down 19.1 pp from a year earlier.
  • Sales of investments increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly sales of investments holds near $0 or moves back toward the trailing-twelve-month quarterly average of $435.64K.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
$1.74M-77.1% YoY
LTMMar 2026
$1.74M-68.9% YoY
Sales of Investments past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year-77.1%——
3-year CAGR+63.6%——
5-year CAGR——
10-year CAGR——

Sales of Investments history

USD · from the cash flow

Latest · FY2025
1.74M USD
Year-over-year change
-77.1%

Sales of Investments vs competitors

How MYO compares with its peers on the latest reported figures

  • MYO's LTM Mar 2026 sales of investments of $1.74M is the largest of the 4 companies compared; the peer median is $0.
  • Its year-over-year change of -68.9% is the highest of 2, against a peer median of -99.9%.
  • Sales of investments amounts to 4.2% of revenue for MYO, versus a peer median of 0.0%.
MYO Competitors Peer median
Sales of Investments for MYO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MYOMyomo, Inc.LTM Mar 2026$1.74M -68.9%+63.6%4.2%
ECORelectroCore, Inc.LTM Mar 2026$5K -99.9%—0.0%
HYPDHyperion DeFi, Inc.LTM Jun 2026$0 ——0.0%
POCIPrecision Optics Corporation, Inc.LTM Mar 2026$0 ——0.0%
Peer median (excluding MYO) $0-99.9%—0.0%

Competitors are the stored peer set for MYO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(10.37M)(10.72M)(8.15M)(6.18M)(15.57M)
Depreciation & Amortization335.96K542.63K517.68K776.97K1.98M
Deferred Income Tax00000
Stock-Based Compensation1.1M1.19M1.12M874.44K2.08M
Change in Working Capital(588.01K)(1.45M)293.21K1.26M(3.86M)
Accounts Receivables(1.05M)47.45K(495.6K)(1.56M)376.97K
Inventory(118.22K)(607.4K)(384.78K)(1.4M)(662.68K)
Accounts Payables1.11M(711.9K)1.79M4.69M(2.9M)
Other Working Capital576.49K(178.13K)(616.54K)(478.7K)(668.57K)
Other Non-Cash Items(19.73K)204.34K48.31K(17.37K)855.86K
Operating Cash Flow(9.55M)(10.23M)(6.17M)(3.29M)(14.51M)
Capital Expenditures(326.46K)(111.79K)(145.82K)(1.36M)(1.74M)
Acquisitions (Net)0(199K)000
Purchases of Investments0(199K)(5.88M)(5.98M)(5.47M)
Sales of Investments0398K4M7.6M1.74M
Other Investing Activities0(199K)00(1.59M)
Investing Cash Flow(326.46K)(310.79K)(2.03M)259.98K(7.06M)
Debt Repayment000011.43M
Common Stock Issued1.1M376.86K9.72M20.37M0
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities12.07M0(8.12K)563.64K0
Financing Cash Flow13.17M376.86K9.71M20.93M11.43M
Effect of Forex Changes(10.39K)(10.93K)14.21K(26.44K)101.7K
Net Change in Cash3.28M(10.18M)1.53M17.88M(10.04M)
Free Cash Flow(9.87M)(10.35M)(6.32M)(4.65M)(16.25M)

Myomo, Inc.

AMEX:MYO

Intrinsic Alpha fair value

Locked

Current Price

$1.25

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.